This company has been marked as potentially delisted and may not be actively trading. Verve Therapeutics (VERV) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Verve Therapeutics (NASDAQ:VERV)CurrentInstitutional OwnershipPercentage97.11%Number ofInstitutional Buyers(last 12 months)124TotalInstitutional Inflows(last 12 months)$190.27MNumber ofInstitutional Sellers(last 12 months)55TotalInstitutional Outflows(last 12 months)$66.49M Get VERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Verve Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data VERV Institutional Buying and Selling by Quarter Verve Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 State of Wyoming12,937$145K0.0%N/A0.015% 8/15/2025 Tower Research Capital LLC TRC 8,773$99K0.0%+125.6%0.010% 8/15/2025 Two Sigma Securities LLC43,402$487K0.1%N/A0.049% 8/15/2025 Rafferty Asset Management LLC75,235$845K0.0%-33.2%0.084% 8/15/2025 Rangeley Capital LLC62,000$696K0.9%N/A0.070% 8/15/2025 Engineers Gate Manager LP18,256$205K0.0%N/A0.020% 8/15/2025 BNP Paribas Financial Markets566,204$6.36M0.0%+9,951.6%0.635% 8/15/2025 Brevan Howard Capital Management LP14,754$166K0.0%-78.0%0.017% 8/15/2025 Bank of America Corp DE485,803$5.46M0.0%-70.2%0.545% 8/15/2025 Ameriprise Financial Inc.103,955$1.17M0.0%+123.8%0.117% Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 AQR Arbitrage LLC208,700$2.34M0.1%N/A0.234% 8/14/2025 Nantahala Capital Management LLC331,437$3.72M0.1%N/A0.372% 8/14/2025 Jane Street Group LLC198,657$2.23M0.0%+97.2%0.223% 8/14/2025 Raymond James Financial Inc.6,288$71K0.0%-44.3%0.007% 8/14/2025 Redmile Group LLC740,261$8.31M0.9%-38.7%0.830% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.86,613$973K0.0%-38.5%0.097% 8/14/2025 Main Street Financial Solutions LLC17,211$193K0.0%N/A0.019% 8/14/2025 The Manufacturers Life Insurance Company 24,926$280K0.0%-3.8%0.028% 8/14/2025 Sei Investments Co.33,785$379K0.0%N/A0.038% 8/14/2025 Harvest Management LLC30,000$337K0.1%N/A0.034% 8/14/2025 Federated Hermes Inc.2,645$30K0.0%+778.7%0.003% 8/13/2025 Gabelli Funds LLC267,520$3.00M0.0%N/A0.300% 8/13/2025 GABELLI & Co INVESTMENT ADVISERS INC.302,400$3.40M0.5%N/A0.339% 8/13/2025 Invesco Ltd.143,445$1.61M0.0%+68.0%0.161% 8/13/2025 Groupe la Francaise95,400$1.07M0.0%N/A0.107% 8/13/2025 Arrowstreet Capital Limited Partnership49,536$556K0.0%N/A0.056% 8/13/2025 Blueshift Asset Management LLC19,483$219K0.1%N/A0.022% 8/13/2025 OMERS ADMINISTRATION Corp371,200$4.17M0.0%N/A0.416% 8/13/2025 New York State Common Retirement Fund12,855$144K0.0%-40.9%0.014% 8/13/2025 Virtus Investment Advisers LLC14,879$167K0.1%-43.5%0.017% 8/13/2025 Hsbc Holdings PLC27,149$307K0.0%-6.4%0.030% 8/12/2025 XTX Topco Ltd38,755$435K0.0%+145.4%0.043% 8/12/2025 American Century Companies Inc.169,168$1.90M0.0%+12.1%0.190% 8/12/2025 Rhumbline Advisers104,721$1.18M0.0%+1.0%0.117% 8/12/2025 Franklin Resources Inc.47,783$537K0.0%+40.0%0.054% 8/12/2025 Legal & General Group Plc66,825$750K0.0%+12.4%0.075% 8/12/2025 JPMorgan Chase & Co.1,141,911$12.82M0.0%+261.2%1.281% 8/12/2025 Swiss National Bank110,200$1.24M0.0%-10.5%0.124% 8/11/2025 Greenland Capital Management LP49,506$556K0.1%N/A0.056% 8/8/2025 Intech Investment Management LLC41,999$472K0.0%-20.8%0.047% BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today8/8/2025 Creative Planning15,837$178K0.0%-22.0%0.018% 8/8/2025 Police & Firemen s Retirement System of New Jersey15,673$176K0.0%-13.8%0.018% 8/8/2025 Bailard Inc.22,800$256K0.0%N/A0.026% 8/8/2025 Geode Capital Management LLC1,704,394$19.14M0.0%+1.3%1.912% 8/7/2025 Allworth Financial LP4,545$51K0.0%+10,229.5%0.005% 8/7/2025 ProShare Advisors LLC43,787$492K0.0%+125.9%0.049% 8/7/2025 Profund Advisors LLC16,210$182K0.0%-31.3%0.018% 8/7/2025 Credit Industriel ET Commercial63,600$714K0.1%N/A0.071% 8/7/2025 Los Angeles Capital Management LLC69,083$776K0.0%-34.8%0.077% 8/5/2025 Alpine Associates Management Inc.2,738,212$30.75M1.6%N/A3.072% 8/1/2025 Clark Asset Management LLC11,494$129K0.0%N/A0.013% 8/1/2025 Teacher Retirement System of Texas15,627$175K0.0%-8.8%0.018% 8/1/2025 Y Intercept Hong Kong Ltd25,736$289K0.0%-50.0%0.029% 8/1/2025 Green Alpha Advisors LLC50,016$562K0.5%-8.2%0.056% 8/1/2025 Alphabet Inc.12,168,489$136.65M6.4%-1.5%13.651% 7/31/2025 Nisa Investment Advisors LLC7,485$84K0.0%-82.5%0.008% 7/31/2025 AlphaQuest LLC39,455$443K0.0%N/A0.044% 7/30/2025 DekaBank Deutsche Girozentrale24,000$270K0.0%-10.1%0.027% 7/29/2025 Nordea Investment Management AB675,849$7.62M0.0%N/A0.758% 7/28/2025 Credit Industriel ET Commercial63,600$714K0.1%N/A0.071% 7/25/2025 CWM LLC15,352$172K0.0%-43.6%0.017% 7/24/2025 IFP Advisors Inc9,639$117K0.0%+17.0%0.011% 7/23/2025 KLP Kapitalforvaltning AS10,200$115K0.0%-43.0%0.011% 7/11/2025 Farther Finance Advisors LLC2,477$28K0.0%+8,746.4%0.003% 7/9/2025 Harbor Capital Advisors Inc.44,601$501K0.0%+53.9%0.050% 6/27/2025 Goldman Sachs Group Inc.1,413,118$6.46M0.0%+90.7%1.585% 6/18/2025 Voya Investment Management LLC19,667$90K0.0%-11.3%0.022% 5/29/2025 Rhumbline Advisers103,707$474K0.0%-6.7%0.116% 5/21/2025 Acadian Asset Management LLC30,803$140K0.0%+126.2%0.035% 5/19/2025 Jane Street Group LLC100,734$460K0.0%-21.0%0.113% 5/16/2025 Woodline Partners LP2,767,719$12.65M0.1%N/A3.105% 5/16/2025 Goldman Sachs Group Inc.1,413,118$6.46M0.0%+90.7%1.585% 5/16/2025 Millennium Management LLC2,110,774$9.65M0.0%-46.1%2.368% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.140,727$647K0.0%-2.8%0.158% 5/16/2025 Jacobs Levy Equity Management Inc.651,883$2.98M0.0%-64.7%0.731% 5/16/2025 AQR Capital Management LLC373,207$1.71M0.0%+1,028.7%0.419% 5/15/2025 Redmile Group LLC1,207,164$5.52M0.5%-8.4%1.354% 5/15/2025 Cubist Systematic Strategies LLC91,330$417K0.0%-22.3%0.102% 5/15/2025 Alpine Global Management LLC12,576$57K0.0%N/A0.014% 5/15/2025 Trexquant Investment LP588,417$2.69M0.0%-7.5%0.660% 5/14/2025 Ieq Capital LLC69,170$316K0.0%N/A0.078% 5/14/2025 Rafferty Asset Management LLC112,582$514K0.0%-17.5%0.126% 5/14/2025 FORA Capital LLC11,971$55K0.0%N/A0.013% 5/14/2025 Pale Fire Capital SE34,500$158K0.0%-23.0%0.039% 5/14/2025 T. Rowe Price Investment Management Inc.2,491,949$11.39M0.0%+5.9%2.795% 5/14/2025 Hsbc Holdings PLC29,010$139K0.0%N/A0.033% 5/14/2025 Wellington Management Group LLP244,183$1.12M0.0%-32.5%0.274% 5/13/2025 Algert Global LLC128,915$589K0.0%-31.4%0.145% 5/13/2025 American Century Companies Inc.150,876$690K0.0%+18.4%0.169% 5/13/2025 Fox Run Management L.L.C.49,954$228K0.0%N/A0.056% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo5/13/2025 E Fund Management Co. Ltd.10,522$48K0.0%N/A0.012% 5/13/2025 Russell Investments Group Ltd.35,697$163K0.0%-53.1%0.040% 5/12/2025 Nuveen LLC1,324,669$6.05M0.0%N/A1.486% 5/12/2025 Invesco Ltd.85,360$390K0.0%+49.4%0.096% 5/12/2025 Swiss National Bank123,100$563K0.0%-7.5%0.138% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.54,824$251K0.0%+9.1%0.062% 5/9/2025 Deutsche Bank AG61,653$282K0.0%-5.0%0.069% 5/9/2025 Charles Schwab Investment Management Inc.568,184$2.60M0.0%-0.4%0.637% 5/9/2025 Vanguard Group Inc.3,955,099$18.08M0.0%-1.3%4.437% 5/8/2025 US Bancorp DE8,513$39K0.0%-72.2%0.010% (Data available from 1/1/2016 forward) VERV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VERV shares? During the previous two years, 179 institutional investors and hedge funds held shares of Verve Therapeutics. The most heavily invested institutionals were Alphabet Inc. ($136.65M), BVF Inc. IL ($38.94M), Nikko Asset Management Americas Inc. ($34.35M), Alpine Associates Management Inc. ($30.75M), Schonfeld Strategic Advisors LLC ($21.37M), State Street Corp ($20.59M), and Geode Capital Management LLC ($19.14M).Learn more on Verve Therapeutics' institutional investors. What percentage of Verve Therapeutics' stock is owned by institutional investors? 97.11% of Verve Therapeutics' stock is owned by institutional investors. Learn more on VERV's institutional investor holdings. Which institutional investors have been buying Verve Therapeutics' stock? Of the 157 institutional investors that purchased Verve Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($6.25M), Woodline Partners LP ($2.77M), Alpine Associates Management Inc. ($2.74M), ARK Investment Management LLC ($1.87M), Vanguard Group Inc. ($1.60M), Federated Hermes Inc. ($1.58M), and Point72 Asset Management L.P. ($1.39M). How much institutional buying is happening at Verve Therapeutics? Institutional investors have bought a total of 28,273,723 shares in the last 24 months. This purchase volume represents approximately $190.27M in transactions. Which of Verve Therapeutics' major shareholders have been selling company stock? Of the 55 institutional investors that sold Verve Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($2.91M), Bank of America Corp DE ($1.38M), JPMorgan Chase & Co. ($1.27M), Jacobs Levy Equity Management Inc. ($1.20M), Redmile Group LLC ($723.15K), Cubist Systematic Strategies LLC ($587.30K), and Nuveen Asset Management LLC ($355.95K). How much institutional selling is happening at Verve Therapeutics? Institutional investors have sold a total of 10,424,608 shares in the last 24 months. This volume of shares sold represents approximately $66.49M in transactions. Related Companies Beam Therapeutics Institutional Ownership Lantheus Institutional Ownership Arcellx Institutional Ownership Akero Therapeutics Institutional Ownership Zai Lab Institutional Ownership Mirum Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership Protagonist Therapeutics Institutional Ownership Apellis Pharmaceuticals Institutional Ownership Metsera Institutional Ownership This page (NASDAQ:VERV) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts